Profil
Serguei Nabirotchkine is the founder.
He founded Pharnext SA in 2007 and currently holds the title of Vice President & Head-Systems Biology.
Dr. Nabirotchkine also held the position of Director-Animal Model Department at Serono Genetics Institute SA.
Postes actifs de Serguei Nabirotchkine
| Sociétés | Poste | Début |
|---|---|---|
| PHARNEXT SCA | Founder | 01/01/2007 |
Anciens postes connus de Serguei Nabirotchkine
| Sociétés | Poste | Fin |
|---|---|---|
Serono Genetics Institute SA
 Serono Genetics Institute SA Miscellaneous Commercial ServicesCommercial Services Part of Merck KGaA, Serono Genetics Institute SA is a French biotechnology company specializing in synthetic DNA and genetic analysis. The private company is based in Paris, France. The company was founded in 1989 by Pascal Brandys. Serono Genetics Institute was acquired by Serono SA on September 23, 2002 for $65.82 million. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PHARNEXT SCA | Health Technology |
| Entreprise privées | 1 |
|---|---|
Serono Genetics Institute SA
Serono Genetics Institute SA Miscellaneous Commercial ServicesCommercial Services Part of Merck KGaA, Serono Genetics Institute SA is a French biotechnology company specializing in synthetic DNA and genetic analysis. The private company is based in Paris, France. The company was founded in 1989 by Pascal Brandys. Serono Genetics Institute was acquired by Serono SA on September 23, 2002 for $65.82 million. | Commercial Services |
